Isoleucine is one of the three branched-chain essential amino acids (with leucine and valine), named for its isomer-of-leucine structure: a hydrophobic side chain that packs into protein cores and a branch point that only muscle can metabolise well. Adults need roughly 20 mg per kg per day; meat, dairy, eggs, and legumes supply it. Its catabolism shares the branched-chain pathway — transamination by the B6-dependent transaminase, then the shared dehydrogenase complex whose failure is maple syrup urine disease.
Muscle fuel: skeletal muscle oxidises isoleucine for energy during exercise — the BCAAs are the amino acids muscle actually burns.
Protein structure: its hydrophobic branch packs into interiors and membranes, including the folded core of haemoglobin; substitution errors (as in sickle trait's neighbour mutations) reshape function.
Glucogenic product: its carbon skeleton yields succinyl-CoA and acetyl-CoA, feeding both sides of the energy economy.
Sources & Absorption
Shared intestinal transporters absorb it; the branched-chain amino acids compete for the same carrier, a fact supplement formulas respect.
Complete proteins rank it mildly below leucine; milk, whey, and soy isolates are BCAA-rich foods.
Body stores are structural — there is no free reserve, so daily intake and protein turnover supply the flux.
Deficiency & Toxicity
No isolated deficiency exists outside protein insufficiency; experimental depletion reduces muscle protein synthesis with leucine and valine.
Maple syrup urine disease — the shared dehydrogenase's failure — accumulates all three BCAAs and their ketoacids, with the sweet urine odour, neonatal encephalopathy, and lifelong protein management.
No toxic ceiling is set; massive single-dose BCAA experiments perturb brain amine uptake through the shared transporter.
Interactions
With B vitamins: the pathway's transaminase is B6-dependent; the dehydrogenase complex mirrors pyruvate's — thiamine-dependent (see B1).
Competition: the three BCAAs and aromatic amino acids share the brain's large-neutral transporter — the theoretical basis of tryptophan/tyrosine availability effects.
With insulin:insulin drives BCAAs into muscle; the post-meal dip in plasma BCAAs is its signature.